Introduction:

Diabetes mellitus each year increases its incidence among the diagnosed and undiagnosed cases at the global level. Since this disease brings as a consequence a neuropathic and vascular damage, diabetic foot ulcers are considered to be the main cause of non-traumatic amputations. Prompt treatment with Heberprot-P® has improved the healing of these ulcers.

Objective:

To characterize patients with diabetic foot ulcer treated with Heberprot-P®.

Methods:

Retrospective descriptive study in 312 individuals diagnosed with diabetic foot ulcer treated with Heberprot-P® in "General Calixto García Iñiguez" University-Teaching- Clinical-Surgical Hospital from 2013 to 2017. The variables collected were: age, sex, type of diabetes, Wagner, vascular damage, dosage, evolution.

Results:

79.7% of the cases were 50 or more years old; men predominated being the 63.4% and 93.6% presented diagnosis of diabetes mellitus type 2. The 35% of the ulcers were in stage 3 of Wagner classification and the most frequently dose range used was 5 to 10 dosages. Vascular damage was observed in the 23.8%, with 76.6% of total healing and only the 8.9% were amputated.

Conclusions:

Men over 50 years old being type 2 diabetics present with frecuency diabetic foot ulcer. The majority of patients treated with Heberprot-P® healed and there were few amputations.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )